Lara Roberts/LinkedIn
Oct 16, 2025, 06:13
Lara Roberts Published “Anticoagulation in Cirrhosis: The New Standard”
Nazim Arain, Consultant Internal Medicine & Gastroenterologist at Almana Group of Hospitals, shared a post on LinkedIn:
“Anticoagulation in Cirrhosis: The New Standard
Patients with cirrhosis face an increased risk of thrombotic events like AF and VTE.
It’s now accepted that their coagulation is “rebalanced,” making anticoagulation the standard of care to reduce stroke/thrombosis risk!
The primary bleeding risk is linked to portal hypertension, NOT general clotting deficiency.
Direct Oral Anticoagulants (DOACs) can be considered for Child-Pugh A & B patients.
LMWH often preferred in Child-Pug-C.”
Title: Anticoagulation in cirrhosis
Authors: Lara Roberts
Read the full review here.
Stay updated with Hemostasis Today.
-
May 1, 2026, 15:26Moustafa Abdou: Tumor Lysis Syndrome Is a Preventable but Life-Threatening Oncologic Emergency
-
May 1, 2026, 15:06Ahmed Koriesh: Celebrating Our Stroke Team and Award Recipients at CCF Florida
-
May 1, 2026, 14:57IACH 2026 Travel Grant and Free Registration for Young Professionals
-
May 1, 2026, 14:56Serena Miranda: Why My Stroke Recovery Made Disability Insurance Personal
-
May 1, 2026, 14:43Michael Makris։ New NEJM Paper Reports Results of Mim8 in Hemophilia A
-
May 1, 2026, 14:32Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
-
May 1, 2026, 14:16Violeta Jardin: Precision-Guided Systemic Thrombolysis in High-Risk PE
-
May 1, 2026, 14:11Austin Manning: Mercy San Juan Medical Center’s Role in Kristen’s Stroke Recovery and Hope
-
May 1, 2026, 14:01Andrew M. Ibrahim: AI in Stroke Care and the Evidence Gap in Healthcare Delivery